biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by currency24on Feb 23, 2015 7:22pm

163 Views

Post# 23457053

PRICE ACTION?DOWN?UP? NEAR FUTURE WILL TELL?

As projected over the weekend, the next move in price was down from the $1.15 area, closed today at $1.11, awaiting a break of the next level on the DOWN SIDE, if this happens then next stop would be the 74 cent area.

There is some upside above $1.15 but limited and a lot of Selling Pressure above $1.14.

MKTS Conditions are not in BTI favor, either, very very limited upside and Wide Open Down Side, the Exit Door is small when the crowd rushes for it.

BIO tech stocks, like Resource stocks High Risk at these stages.

All the above in my humble opinion and based on MKTS.

Bullboard Posts

Critical materials crisis: Diversifying away from China’s monopoly